Limelight Bio is a user of LinkedIn and maintains a corporate account using the screen name: limelight-bio.

Limelight Bio recognizes the importance of social media, including LinkedIn, and new communication channels that enable Limelight Bio to engage in interactive discussion with the Company’s stakeholders. As a development-stage biopharmaceutical company, Limelight Bio is committed to abide by the legal, ethical and regulatory standards applicable to the Company. By maintaining an active LinkedIn account, Limelight Bio aims to responsibly interact with stakeholders.


Limelight Bio may respond to questions and comments presented via LinkedIn when appropriate. Limelight Bio may not be able to immediately respond to questions or comments, and responses, if any, may be limited in nature.

There may be questions and/or comments Limelight Bio cannot address, including, but not limited to, questions related to non-public confidential information, proprietary information, financial matters, ongoing legal matters, regulatory issues and other aspects of Limelight Bio’s business. Limelight Bio will not respond to rumors, personal attacks, foul language, disparaging comments or topics that do not relate directly to Limelight Bio.

LinkedIn accounts that Limelight Bio follows or is followed by do not indicate an endorsement of the account owner or their products and services.

Limelight Bio may provide links or references to external websites, not controlled by Limelight Bio, as part of its Tweets. However, Limelight Bio does not endorse or claim responsibility for the content of such other websites. Any links or references to such external websites are provided as merely a convenience to the users of the LinkedIn platform.

Limelight Bio reserves all rights relating to the Limelight Bio LinkedIn account (limelight-bio) including, but not limited to, all rights to add, remove or modify any content or material posted on the account, discontinue the account, accept or reject those who may wish to follow the account and respond to, or refrain from responding to, any questions or comments addressed to the account.

Limelight Bio is a privately held, multi-platform, multi-disease biopharmaceutical company headquartered in Philadelphia, PA and Cambridge, MA. Since 2017, Limelight has been developing proprietary technologies, advanced targets, and leading drug candidates designed to overcome key limitations of current gene therapy and gene editing approaches.

  • LinkedIn Social Icon

©2019 Limelight Bio, Inc. All Rights Reserved.